危重急性呼吸衰竭患儿红细胞输注建议:儿科重症输血与贫血专家倡议
儿科重症输血与贫血专家倡议通过共识会议制定危重患儿红细胞输注建议,呼吸亚组6名专家参与,系统检索1980年至2017年5月文献,采用RAND/UCLA适当性方法和GRADE分级。共形成7条聚焦急性呼吸衰竭患儿的推荐,全部达成>80%同意。血红蛋白<5 g/dL时强烈推荐输注红细胞;血流动力学稳定且血红蛋白≥7 g/dL时强烈推荐不常规输注。对血流动力学不稳定、严重低氧血症或血红蛋白5-7 g/dL的患儿专家未能给出推荐,基于生理指标和生物标志物的具体输血策略亦未能制定。
要点
- 急性呼吸衰竭患儿血红蛋白<5 g/dL时,专家倡议强烈推荐输注红细胞。
- 血流动力学稳定且血红蛋白≥7 g/dL的呼吸衰竭患儿,强烈推荐不常规输注红细胞。
- 血流动力学不稳定、严重低氧血症或血红蛋白5-7 g/dL的患儿,专家未能给出推荐。
- 基于生理学指标和生物标志物的具体红细胞输注策略未能制定。
- 全部7条推荐均达成>80%同意,证据不足时采用专家共识推荐。
适用人群与场景
- 危重急性呼吸衰竭患儿。
- 推荐适用于血红蛋白<5 g/dL或血流动力学稳定且血红蛋白≥7 g/dL的急性呼吸衰竭患儿。
- 血流动力学不稳定、严重低氧血症或血红蛋白5-7 g/dL的患儿未达成推荐。
诊断标准与关键阈值
- 血红蛋白<5 g/dL:强烈推荐输注红细胞。
- 血流动力学稳定且血红蛋白≥7 g/dL:强烈推荐不常规输注红细胞。
- 血红蛋白5-7 g/dL:专家未能给出推荐。
处置流程与药物剂量
- 急性呼吸衰竭患儿血红蛋白<5 g/dL时输注红细胞(强烈推荐)。
- 血流动力学稳定且血红蛋白≥7 g/dL的急性呼吸衰竭患儿不常规输注红细胞(强烈推荐)。
- 血流动力学不稳定或严重低氧血症的患儿,红细胞输注决策未能给出推荐。
- 基于生理学指标和生物标志物的具体输血策略未能制定。
研究设计与关键结果
- 儿科重症输血与贫血专家倡议共38名专家参与,呼吸亚组6名专家,系统检索PubMed、EMBASE和Cochrane Library数据库1980年至2017年5月文献。
- 采用RAND/UCLA适当性方法达成共识,GRADE方法总结结果,共形成7条聚焦急性呼吸衰竭患儿的推荐,全部达成>80%同意。
- 血红蛋白<5 g/dL时强烈推荐输注红细胞;血流动力学稳定且血红蛋白≥7 g/dL时强烈推荐不常规输注红细胞。
- 对血流动力学不稳定、严重低氧血症或血红蛋白5-7 g/dL的患儿未能给出推荐;基于生理指标和生物标志物的具体输血策略未能制定。
证据类型、等级与局限
- 证据类型:国际多学科专家共识会议(儿科重症输血与贫血专家倡议),采用GRADE方法分级。
- 推荐达成>80%同意;证据不足时制定基于专家的临床推荐。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对急性呼吸衰竭患儿,血红蛋白<5 g/dL时可依据该强烈推荐输注红细胞。
- 对血流动力学稳定且血红蛋白≥7 g/dL的急性呼吸衰竭患儿,不常规输注红细胞(强烈推荐)。
- 对血流动力学不稳定、严重低氧血症或血红蛋白5-7 g/dL的患儿,该倡议未给出推荐,床旁决策需个体化。
- 基于生理学指标和生物标志物的输血策略尚无法用于临床决策。
指南或共识出处
- Pediatric Critical Care Transfusion and Anemia Expertise Initiative(儿科重症输血与贫血专家倡议)共识会议推荐,发表于Pediatric Critical Care Medicine。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To present the recommendations and supporting literature for RBC transfusions in critically ill children with bleeding developed by the Pediatric Critical Care Transfusion and Anemia Expertise Initiative.
DESIGN: Consensus conference series of international, multidisciplinary experts in RBC transfusion management of critically ill children.
METHODS: The panel of 38 experts developed evidence-based and, when evidence was lacking, expert-based clinical recommendations as well as research priorities for RBC transfusions in critically ill children. The respiratory subgroup included six experts. Electronic searches were conducted using PubMed, EMBASE, and Cochrane Library databases from 1980 to May 2017. Agreement was obtained using the Research and Development/UCLA Appropriateness Method. Results were summarized using the Grading of Recommendations Assessment, Development, and Evaluation method.
RESULTS: Transfusion and Anemia Expertise Initiative experts developed seven recommendations focused on children with acute respiratory failure. All recommendations reached agreement (> 80%). Transfusion of RBCs in children with respiratory failure with an hemoglobin level less than 5 g/dL was strongly recommended. It was strongly recommended that RBCs not be systematically administered to children with respiratory failure who are hemodynamically stable and who have a hemoglobin level greater than or equal to 7 g/dL. Experts could not make a recommendation for children with hemodynamic instability, with severe hypoxemia and/or with an hemoglobin level between 5 and 7 g/dL. Specific RBC transfusion strategies using physiologic-based metrics and biomarkers could not be elaborated.
CONCLUSIONS: The Transfusion and Anemia Expertise Initiative Consensus Conference developed specific recommendations regarding RBC transfusion management in critically ill children with respiratory failure, as well as recommendations to guide future research. Clinical recommendations emphasize relevant hemoglobin thresholds. Research recommendations emphasize the need to identify appropriate physiologic thresholds, suggest a better understanding of alternatives to RBC transfusion, and identify the need for better evidence on hemoglobin thresholds that might be used in specific subpopulations of critically ill children.
参考来源
- Demaret P, Emeriaud G, Hassan NE, et al. Recommendations on RBC Transfusions in Critically Ill Children With Acute Respiratory Failure From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative. Pediatr Crit Care Med. 2018. PMID: 30161065. doi:10.1097/PCC.0000000000001619
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。